Avantor reported third-quarter 2026 net sales of $1,698.3 million, a 4.6% increase from the prior year period, driven by organic growth of 5.2%. Diluted GAAP earnings per share were $0.30, compared to a loss of $1.04 in the same quarter last year, while adjusted diluted EPS was $0.22. The company also raised its full-year fiscal 2026 guidance for organic revenue growth to +0.75% to +1.25%, adjusted EPS to $0.81–$0.83, and free cash flow to $525M–$550M. Avantor is a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries.
